Q1 2025 Management View CEO Thomas Edward Capasse reported that the company maintained a stable book value per share at $10.61 during Q1 2025. Key actions included completing the UDF merger, which ...

Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...